Pay in 4 interest-free payments of $5.25 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Semaglutide is an FDA-approved GLP-1 receptor agonist originally developed for type 2 diabetes management that has also been approved for chronic weight management under the brand name Semaglutide (GLP-1 weight loss)
[PMID: 29667297] PubMed record related to this compound for laboratory literature review
Repeated freeze-thaw cycles of reconstituted solution stress the peptide structurally and accelerate aggregation
Li N, Zhou H, Wu H, Wu Q, Duan M, Deng W, Tang Q
US$ 26.82
US$ 24.75
US$ 29.91
